Mark P. Wentland
Professor Emeritus
Department of Chemistry and Chemical Biology
Cogswell Laboratory
110 8th Street
Rensselaer Polytechnic Institute, Troy, NY 12180-3590
Personal email: mark.p.wentland(at)gmail(dot)com

Abbreviated Biosketch

Our Group's Research:

• Samidorphan: Discovery of a critical component of FDA-approved LYBALVI.
   -  Samidorphan featured on the front cover of the C&EN Supplement:
              "The 2015 Top 20 Drugs In The Pipeline"
• Study of the Pathways of Morphine's Pain-relieving Properties
• Rensselaer chemistry team members, 1994-2015
• Collaborators:
   -  Dr. Jean Bidlack and coworkers (U of Rochester)
   -  Discovery and development personnel at Alkermes, Inc.
   -  Dr. Lindsay Hough and coworkers (Albany Medical College)
• Funding for medicinal chemistry activities from these sources is gratefully acknowledged:
   -  NIH/NIDA (click here for details)
   -  AMRI, Inc. (click here for details)
• List of Publications from PubMed database

Mark Wentland's Teaching/Lecture Activities:
• Courses taught at RPI over the past decade (course descriptions):
   -  Medicinal Chemistry (example module)
   -  Drug Discovery (example module)
   -  Drug Discovery Laboratory (example experiment)